Recorded last week at Fierce Biotech Week in Boston, this episode of “The Top Line” features a conversation with Kristen ...

How the ouster of key officials at the FDA has created anxiety and uncertainty for the developers of rare disease drugs.

On Saturday, Rami Elghandour learned that the university had canceled his speech after complaints over his social media posts ...

REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage company developing next-generation cancer therapies, today announced that Gil Efron, Chief ...

Abivax CEO Marc de Garidel told CNBC that the terms of any future deal will be better after it releases data on a key trial in the second quarter. Intense takeover rumors have surrounded the French ...

John Oyler, Co-founder, Chairman and CEO at BeOne Medicines, discusses the company's business strategy and the outlook for the biotech sector. He speaks with Avril Hong and Paul Allen from the ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.